Using functional magnetic resonance imaging to investigate the efficacy of menthol in chemotherapy induced peripheral neuropathy (CIPN) Topical treatment with 3% menthol gel in patients with chemotherapy induced peripheral neuropathy (CIPN) will have central efficacy as demonstrated by alterations in pain network activation on fMRI. Chief Investigator: Prof Marie Fallon For further information on this trial please use this link: http://controlled-trials.com/ISRCTN69917256 ECTU contact: Allan Walker (allan.walker@ed.ac.uk ) ECTU involvement: Data base design, Randomisation service. This article was published on 2024-09-24